Cephalozin
Drug1000 mg Cephalozin
Other names: Kefzol
NCT Number: NCT02225821
In the Netherlands about 18,000 surgical procedures with implant removal are annually performed after fracture healing, of which 30-80% concern the foot, ankle and lower leg region. For clean surgical procedures, the rate of postoperative wound infections (POWIs) should be less than 5%. However, rates of 10-12% following implant removal, specifically after foot, ankle and lower leg fractures are reported. Currently, surgeons decide individually if antibiotics prophylaxis is given, since no guideline exists. This leads to undesirable practice variation.
Therefore, the investigators propose a double-blind randomized controlled trial (RCT) in patients scheduled for implant removal following a foot, ankle or lower leg fracture, to assess the (cost-)effectiveness of a single gift of antibiotic prophylaxis. Primary outcome is a POWI within 30 days after implant removal. Secondary outcomes are quality of life, functional outcome at 30 days and 6 months after implant removal and costs.
With 2 x 250 patients a decrease in POWI from 10% to 3.3% (expected rate in clean-contaminated elective orthopedic trauma procedures) can be detected (Power=80%, 2-sided alpha=5%, including 15% lost to follow up).
If the assumption of the investigators, that prophylactic antibiotics prior to implant removal reduces the infectious complication rate, is confirmed by this RCT, this will offer a strong argument to adopt a single gift of antibiotic prophylaxis as standard practice of care. This will reduce the incidence of POWIs and consequently will lead to less physical and social disabilities and health care use. In addition, it will decrease the rate of use of empiric broad-spectrum antibiotics (and antibiotic resistance) prescribed upon suspicion or diagnosis of a POWI. A preliminary, conservative estimation suggests yearly cost savings in the Netherlands of €3.5 million per year.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 4
Medisch Centrum Alkmaar, Alkmaar, Netherlands
See study protocol
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1000 mg Cephalozin
Other names: Kefzol
10 cc of NaCl 0.9%
Other names: NaCl 0.9%
Time frame: 30 days
The primary outcome variable is a POWI within 30 days after implant removal as defined by the criteria applied by the Centers for Disease and Control.
Time frame: baseline, one month, 6 months
Health-related quality of life (as measured by the EQ-5D questionnaire)
Time frame: baseline, 1 month, 6 months
Functional outcome following implant removal as assessed with the Lower Extremity Functional Scale (LEFS). The LEFS can be used by clinicians as a measure of patients' initial function, ongoing progress and outcome, as well as to set functional goals. The LEFS can be used to evaluate the functional impairment of a patient with a disorder of one or both lower extremities. It can be used to monitor the patient over time and to evaluate the effectiveness of an intervention
Time frame: 1 month, 6 months
Patient satisfaction following implant removal as measured by a ten-point Visual Analog Scale
Time frame: baseline, 1 month, 6 months
Health care resources utilization at baseline, 1 month and 6 months after implant removal (including amongst others, number of visits to the general practitioner and use of home care organizations) as measured by way of a combination of the Dutch iMTA Medical Consumption Questionnaire (iMCQ) and iMTA Productivity Cost Questionnaire (iPCQ) (adapted to the study setting).
Time frame: Costs per quality adjusted life year
Costs (economic evaluation including budget impact analysis): the economic evaluation of antibiotic prophylaxis in patients scheduled for implant removal (following a foot, ankle or lower leg fracture) against no prophylaxis as its best alternative will be performed as a cost-effectiveness (CEA) as well as a cost-utility (CUA) analysis.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Other
Antibiotic Prophylaxis to Prevent Wound Infections Following Implant Removal
Acronym: WIFI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06263205
Digestive System Diseases, Digestive System Neoplasms
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04955730
Infections, Pathologic Processes
Tampa, Florida, United States
View Trial DetailsNCT06702878
Anti-Infective Agents, Bacterial Infections
Englewood, Colorado, United States
View Trial DetailsNCT07573033
Dry Socket, Facial Pain
Karachi, Sindh, Pakistan
View Trial Details